AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...

The company is recalling the affected lot due to the "defective delivery system", the USFDA's enforcement report stated.

Ahmedabad: The Income Tax Appellate Tribunal (ITAT) in Ahmedabad has upheld the disallowance of more than Rs 9.81 crore ...

Vandalia Fire posted on social media that several fire departments responded after an explosion on the roofing of a ...

Takeda Pharmaceutical offers a strong cash position and an above-average dividend yield. Find out why I'm bullish on TAK ...

Mankind Pharma sealed the Rs 13,630 crore acquisition of private equity firm Advent International owned Bharat Serums and ...

This video provides an in-depth analysis of the current stock market trends, specifically focusing on the pharmaceutical, real estate, and metal sectors. It highlights the stocks in these industries ...

Astellas is rolling out its first DTC campaign to raise awareness about an injection that treats geographic atrophy.

Siddhart Khemka, a prominent figure in the financial industry, provides his analysis on the reasons behind this underperformance. He shares his perspective on the factors influencing the Nifty Pharma ...

In the latest development, the Indian Pharmaceutical Alliance (IPA) has reacted to the recent report by the Central Drugs Standard Control Organisation (CDSCO) according to which over 50 drugs ...

Avasthi offers his insights on Lupin, Aurobindo Pharma, Piramal, and Syngene, and is particularly bullish on Dr. Reddy's due to its strong domestic performance, growth in the U.S. market, and ...